EASL Studio Podcast: EASL CPGs on Vascular Liver Diseases: What’s New? episode artwork

EPISODE · Jun 19, 2025 · 33 MIN

EASL Studio Podcast: EASL CPGs on Vascular Liver Diseases: What’s New?

from EASL Video Podcasts

This episode addresses key challenges in vascular complications of liver disease, including the management of portal vein thrombosis (PVT) in patients with and without cirrhosis. Experts will explore controversies surrounding long-term anticoagulation therapy and discuss insights from the CIRROXABAN paper. Additionally, the episode will shed light on the management of splanchnic artery aneurysms, offering valuable guidance for clinical practice. Moderator:  Pierre-Emmanuel Rautou Faculty: Sarwa Darwish Murad, Juan-Carlos Garcia-Pagan, Valérie Vilgrain  Related episodes S4E11 – YI Choice: Gene therapy for liver disease — RNA interference and beyond S4E6 – Regenerating the liver graft with a machine? S3E11 – Regenerative Hepatology: From stem cells to tissue engineering S2E9 – YI Choice: Propelling liver cell biology into the third dimension All EASL Studio Podcasts are available on EASL Campus. Click here to see all EASL Video Podcasts on Apple Podcasts.

Episode metadata supplied by the publisher feed · Published Jun 19, 2025

Embed this episode

NOW PLAYING

EASL Studio Podcast: EASL CPGs on Vascular Liver Diseases: What’s New?

0:00 33:14

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of EASL Video Podcasts?

This episode is 33 minutes long.

When was this EASL Video Podcasts episode published?

This episode was published on June 19, 2025.

Can I download this EASL Video Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!